Eli Lilly commits $85 million upfront and over $1.8 billion in potential milestones to partner with Repertoire Immune Medicines, aiming to develop a new class of 'tolerizing' therapies that reset the immune system without broad suppression.
The protective packaging leader's 2025 recycling achievement, driven by customer partnerships and its EmeraldPak product, marks a significant step in its 'Stairway to Green' initiative and underscores growing industry momentum for closed-loop systems.
A new global survey from JPMorgan Private Bank shows wealthy families remain overwhelmingly cautious on cryptocurrency investments, with a strong preference for traditional portfolio strategies despite market hype.
Private equity firm RoundTable Healthcare Partners has acquired the dermatologist-trusted skincare and sun protection brand Colorescience from 1315 Capital, as the company's annual sales approach the $100 million mark.
As Uber Technologies prepares to report earnings, investors are weighing the long-term promise of its autonomous vehicle initiatives against immediate regulatory cost pressures in key markets like New York and France.
Opera's shares soared nearly 18% after the browser company integrated Tether's dominant USDT stablecoin into its MiniPay wallet, highlighting investor optimism around its Web3 strategy despite unanswered questions on long-term monetization.
Clinical-stage biotech Erasca (ERAS) has seen its stock skyrocket over the past 12 months, hitting a multi-year high. While technical momentum is strong, the company remains pre-revenue, with its fate tied to future drug approvals, presenting a classic high-risk, high-reward scenario for investors.
In a strategic reshuffle following the exit of its product chief, Netflix has merged its product and technology divisions under veteran executive Elizabeth Stone, signaling a tighter integration of engineering and user experience.
CNBC's Jim Cramer tempered enthusiasm for Novo Nordisk stock, suggesting investors hold rather than buy after its massive gains driven by blockbuster weight-loss drugs.
Business Facilities magazine has named North Carolina its 'State of the Year' for business climate and economic development, the state's third such win in six years, following a surge of multi-billion dollar investments from tech and manufacturing giants.
Dropbox shares have faced significant pressure over the past year, declining roughly 20% and raising questions about its long-term growth trajectory. As the stock trades below key fair value estimates, investors are divided on whether this represents a buying opportunity or reflects deeper challenges in the competitive cloud storage market.
Ukraine's defense minister confirms collaborative efforts with SpaceX have yielded initial success in countering Russia's unauthorized use of Starlink terminals to guide attack drones, with a new verification system imminent.
Newly unsealed correspondence contradicts CEO's prior statements, sparking investor concern amid broader challenges for the electric vehicle maker.
IDEAYA Biosciences shares have retreated from recent highs, sparking debate among investors. While a discounted cash flow model suggests deep undervaluation, price-to-sales metrics paint a contrasting picture of a premium stock. We examine the numbers behind the volatility and what it signals for the precision oncology company's future.
While Wall Street chases the latest weight-loss drug headlines, Novo Nordisk's recent launch of an oral GLP-1 therapy and its entrenched insulin business present a compelling value proposition for long-term investors.
The Detroit automaker has held preliminary talks with Xiaomi and other Chinese manufacturers about potential joint ventures to build electric vehicles in the United States, a move already drawing sharp criticism from Washington lawmakers.
In a significant diplomatic and economic shift, the Trump administration has agreed to slash tariffs on Indian goods after securing a commitment from New Delhi to phase out purchases of Russian crude oil.
While Intel's struggles capture public attention and government subsidies, a less-heralded semiconductor titan, Broadcom, is forging a formidable path in AI through its deep partnership with Alphabet and a business model built for the long haul.
Kalmar Oyj embarks on a strategic, long-term IT transformation with Tata Consultancy Services, building an AI-powered digital core to streamline operations, enhance equipment reliability, and solidify its service-led business model in the competitive port equipment sector.
Navitas Semiconductor is strategically shifting its focus from volatile consumer electronics to the high-growth, high-margin arenas of AI data centers and electric vehicles, underscored by a pivotal partnership with industry giant Nvidia.
